keyword
MENU ▼
Read by QxMD icon Read
search

Fecal calprotectin

keyword
https://www.readbyqxmd.com/read/28204866/vedolizumab-treatment-for-immune-checkpoint-inhibitor-induced-enterocolitis
#1
Viktoria Bergqvist, Erik Hertervig, Peter Gedeon, Marija Kopljar, Håkan Griph, Sara Kinhult, Ana Carneiro, Jan Marsal
Immune checkpoint inhibitors (ICPI), such as ipilimumab [anti-cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibody] and nivolumab or pembrolizumab [anti-programmed cell death protein-1 (PD-1) antibodies], improve survival in several cancer types. Since inhibition of CTLA-4 or PD-1 leads to non-selective activation of the immune system, immune-related adverse events (irAEs) are frequent. Enterocolitis is a common irAE, currently managed with corticosteroids and, if necessary, anti-tumor necrosis factor-α therapy...
February 15, 2017: Cancer Immunology, Immunotherapy: CII
https://www.readbyqxmd.com/read/28196533/assessment-of-complementary-feeding-of-canadian-infants-effects-on-microbiome-oxidative-stress-a-randomized-controlled-trial
#2
Wafaa Qasem, Meghan B Azad, Zakir Hossain, Elnaz Azad, Sarah Jorgensen, Sandra Castillo San Juan, Chenxi Cai, Ehsan Khafipour, Trust Beta, L Jackson Roberts, James Friel
BACKGROUND: The World Health Organization recommends exclusive breastfeeding until 6 months followed by introduction of iron-rich complementary foods (CFs). The aim of this study was to determine the impact of different iron-rich CFs on infant gut inflammation and microbiota. METHODS: Eighty-seven exclusively breastfed infants were randomly assigned to receive one of the following as their first CF: iron-fortified cereal (Cer), iron-fortified cereal with fruit (Cer + Fr), or meat (M)...
February 14, 2017: BMC Pediatrics
https://www.readbyqxmd.com/read/28195066/successful-therapy-of-clostridium-difficile-infection-with-fecal-microbiota-transplantation
#3
P C Konturek, J Koziel, W Dieterich, D Haziri, S Wirtz, I Glowczyk, K Konturek, M F Neurath, Y Zopf
Clostridium difficile infection (CDI) is the most common cause of infectious diarrhea and represents an important burden for healthcare worldwide. Symptoms of severe CDI include watery, foul-smelling diarrhea, peripheral leucocytosis, increased C-reactive protein (CRP), acute renal failure, hypotension and pseudomembranous colitis. Recent studies indicate that the main cause of CDI is dysbiosis, an imbalance in the normal gut microbiota. The restoration of a healthy gut microbiota composition via fecal microbiota transplantation (FMT) recently became more popular...
December 2016: Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society
https://www.readbyqxmd.com/read/28193167/helicobacter-pylori-prevalence-and-clinical-significance-in-patients-with-quiescent-crohn-s-disease
#4
Adi Lahat, Uri Kopylov, Sandra Neuman, Nina Levhar, Doron Yablecovitch, Benjamin Avidan, Batia Weiss, Shomron Ben-Horin, Rami Eliakim
BACKGROUND: Helicobacter pylori (HP) infection is present in about 50% of the global population, and is associated with chronic gastritis, peptic disease and gastric malignancies. HP prevalence in Crohn's disease (CD) patients was shown to be low compared to the general population, and its influence on disease activity is yet to be determined. Our aims were to determine the prevalence of HP in a selected group of CD patients with quiescent disease, and to assess the influence of its eradication on disease activity and endoscopic and laboratory activity measures...
February 13, 2017: BMC Gastroenterology
https://www.readbyqxmd.com/read/28188944/comparison-of-fecal-calprotectin-in-exclusively-breastfed-and-formula-or-mixed-fed-infants-in-the-first-six-months-of-life
#5
Masoumeh Asgarshirazi, Mamak Shariat, Fatemeh Nayeri, Hosein Dalili, Alireza Abdollahi
We conducted this study to compare fecal calprotectin between exclusively breastfed and formula or mixed fed infants aged one month and six months. Sixty term infants were enrolled from the labor ward of Valiasr Hospital between Oct 2011 and July 2015 and their fecal calprotectin was checked by the ELISA method and Hycult biotech kits. The enrolled infants had a birth weight of 2500-4000 g and no perinatal insults or hospitalization. Stool sampling was done at 1±1 week and at 6n±1 months. The six-month infants had no recent disease, antibiotic use or vaccination...
January 2017: Acta Medica Iranica
https://www.readbyqxmd.com/read/28180127/impact-of-fecal-calprotectin-measurement-on-decision-making-in-children-with-inflammatory-bowel-disease
#6
Wael El-Matary, Esmail Abej, Vini Deora, Harminder Singh, Charles N Bernstein
BACKGROUND: The use of fecal calprotectin (FCal) as a marker of intestinal inflammation, in the management of inflammatory bowel disease (IBD) is increasing. The aim of this study was to examine the impact of FCal measurements on decision-making and clinical care of children with IBD. MATERIALS AND METHODS: In a retrospective cohort study, FCal, clinical activity indices, and blood markers were measured in children with established diagnoses of IBD. Pearson correlation coefficient analysis was performed to examine association between FCal and other markers...
2017: Frontiers in Pediatrics
https://www.readbyqxmd.com/read/28175167/p604-usefulness-of-stool-hemoglobin-and-fecal-calprotectin-for-detecting-of-mild-to-moderate-ulcerative-colitis
#7
J S Koo, D J Kim, D-W Lee, Y J Jeen
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175079/p319-accurate-cut-offs-for-predicting-endoscopic-activity-and-mucosal-healing-in-crohn-s-disease-with-fecal-calprotectin
#8
J M Vázquez-Morόn, B Benítez-Rodríguez, H Pallarés-Manrique, F H Machancoses, J L Robles Rodríguez, M Ramos-Lora, C Ruíz-Frutos
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175073/p282-does-colonoscopy-alter-the-post-procedural-fecal-calprotectin-results-in-crohn-s-disease-patients-with-ileocecal-resection
#9
Y Erzin, N Demir, S Bozcan, S Yıldırım, I Hatemi, A F Celik
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175067/p236-fecal-calprotectin-as-suitable-biomarker-in-evaluation-of-histological-disease-activity
#10
T Knezevic Ivanovski, S Knezevic Usaj, V Gligorijevic, S Markovic, P Svorcan, M Nedeljkovic Protic
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175049/p256-correlation-of-fecal-calprotectin-levels-with-endoscopic-severity-evaluated-with-balloon-assisted-endoscopy-in-patients-with-crohn-s-disease
#11
K Matsuoka, F Iwamoto, M Kimura, K Takenaka, T Fujii, M Nagahori, N Enomoto, K Ohtsuka, M Watanabe
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28175030/p148-fecal-calprotectin-as-a-noninvasive-indicator-for-ulcerative-colitis-disease-activity-in-the-korean-cohort
#12
S-H Lee, H Seo, K Chang, E M Song, G-U Kim, M Seo, E J Kwon, S W Hwang, S H Park, D-H Yang, K-J Kim, J-S Byeon, S-J Myung, S-K Yang, B D Ye
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28174747/a-disease-associated-microbial-and-metabolomics-state-in-relatives-of-pediatric-inflammatory-bowel-disease-patients
#13
Jonathan P Jacobs, Maryam Goudarzi, Namita Singh, Maomeng Tong, Ian H McHardy, Paul Ruegger, Miro Asadourian, Bo-Hyun Moon, Allyson Ayson, James Borneman, Dermot P B McGovern, Albert J Fornace, Jonathan Braun, Marla Dubinsky
BACKGROUND & AIMS: Microbes may increase susceptibility to inflammatory bowel disease (IBD) by producing bioactive metabolites that affect immune activity and epithelial function. We undertook a family based study to identify microbial and metabolic features of IBD that may represent a predisease risk state when found in healthy first-degree relatives. METHODS: Twenty-one families with pediatric IBD were recruited, comprising 26 Crohn's disease patients in clinical remission, 10 ulcerative colitis patients in clinical remission, and 54 healthy siblings/parents...
November 2016: Cellular and Molecular Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/28172926/p598-mucosal-and-transmural-healing-during-anti-tnf-therapy-is-fecal-calprotectin-a-marker-of-therapeutic-response
#14
L Bertani, L Ceccarelli, N de Bortoli, E Albano, G Tapete, G Laino, G Mumolo, A Ricchiuti, M Bellini, S Marchi, F Costa
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172901/p581-highly-purified-eicosapentaenoic-acid-as-free-fatty-acid-reduces-fecal-calprotectin-levels-and-prevents-clinical-relapse-in-ulcerative-colitis-patients-a%C3%A2-double-blind-randomized-placebo-controlled-trial
#15
E Scaioli, A Sartini, M Bellanova, M Campieri, D Festi, F Bazzoli, A Belluzzi
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172893/p297-fecal-calprotectin-accurately-predicts-symptomatic-relapse-in-children-and-adolescents-with-inflammatory-bowel-disease-in-clinical-remission
#16
K Diederen, D Hoekman, A Leek, V Wolters, M Benninga, T Hummel, T de Meij, B Koot, M Tabbers, M Benninga, A Kindermann
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172813/p268-fecal-calprotectin-correlates-more-highly-with-endoscopic-disease-activity-than-symptom-based-disease-activity-markers-in-paediatric-psc-ibd
#17
A Ricciuto, J Fish, N Carman, E Crowley, A Muise, P Church, T Walters, B M Kamath, A Griffiths
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172758/p157-fecal-calprotectin-correlates-to-endoscopic-and-histologic-remission-in-ulcerative-colitis-a%C3%A2-prospective-study
#18
L Hart, O Kherad, C Lemieux, J Laneuville, M Chavannes, V Marcus, C Maedler, W Afif, A Bitton, P Brassard, T Bessissow
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172655/p174-optimal-time-interval-required-for-correlation-between-fecal-calprotectin-test-and-endoscopy
#19
S R Jeon, H G Kim, J-O Kim, Y Jung, B M Ko, M S Lee
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28172608/p169-usability-of-a-home-based-test-for-the-measurement-of-fecal-calprotectin-in-ibd-patients
#20
C Bello, A Roseth, J Guardiola, C Reinhard, E Louis
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
keyword
keyword
27773
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"